Topiramate
NDC 69680-177, Topiramate, capsule, extended release, from Vitruvias Therapeutics, Inc..
- Product NDC
- 69680-177
- Status
- Listed
- Labeler
- Vitruvias Therapeutics, Inc.
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215638
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69680-177 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOPIRAMATE25 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69680-177-30 | 69680017730 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (69680-177-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/a9d7c5ef-daf9-4f97-8673-7f4a2007f408NADAC price for package 69680017730
GET /v1/drugs/nadac/69680017730
Use it
Look up 69680-177 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69680-177 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69680-177. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.